PTC Therapeutics enters consulting agreement with departing board member Alethia Young

PTC Therapeutics has engaged former Board member Alethia Young as an independent consultant effective June 8, 2026, following her resignation from the board. The agreement outlines advisory services to management and the board with standard confidentiality and intellectual property protections for a departing director.